Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Interaction Study of Safinamide and Rosuvastatin
NCT03216304Phase 1Completed
- Sponsor
- CROSS Research
- Start
- May 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of safinamide in Parkinson's disease (PD) (2 arms), sponsored by CROSS Research. Primary endpoint: Area Under the Curve at 96 hours. Started May 2017; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03216304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03216304.